Free Trial
OTCMKTS:PARNF

Parnell Pharmaceuticals (PARNF) Stock Price, News & Analysis

Parnell Pharmaceuticals logo
$0.0001
+0.00 (+∞)
(As of 05/31/2024)

About Parnell Pharmaceuticals Stock (OTCMKTS:PARNF)

Key Stats

Today's Range
$0.0001
$0.0001
50-Day Range
N/A
52-Week Range
$0.0001
$0.0001
Volume
2,400 shs
Average Volume
N/A
Market Capitalization
$8,295.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Parnell Pharmaceuticals Holdings Ltd, a commercial-stage pharmaceutical company, focuses on developing, manufacturing, and marketing animal pharmaceutical products worldwide. The company operates through four segments: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. It markets various products, including estroPLAN and GONAbreed reproductive hormone products for enhancing cattle breeding performance; Zydax for the treatment of osteoarthritis (OA) in dogs and horses; and Glyde, a nutraceutical product for the treatment of OA, as well as Parnell PROcept, which adds an additional injection of estroPLAN after the first injection. The company also offers mySYNCH, a digital tool to help veterinarians and producers optimize reproduction and maximize economic gains. Parnell Pharmaceuticals Holdings Ltd was incorporated in 2009 and is headquartered in Alexandria, Australia.

Receive PARNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Parnell Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

PARNF Stock News Headlines

Parnell Pharmaceuticals Holdings Ltd.
CRUSHED: How Biden's Replacement Will Devastate Your 401(k)!
Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.
Parnell Pharmaceuticals Holdings Ltd (PARNF)
See More Headlines

PARNF Stock Analysis - Frequently Asked Questions

Parnell Pharmaceuticals' stock was trading at $0.0001 at the start of the year. Since then, PARNF shares have increased by 0.0% and is now trading at $0.0001.
View the best growth stocks for 2024 here
.

Shares of PARNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Today
11/04/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:PARNF
Previous Symbol
NASDAQ:PARN
CIK
N/A
Fax
N/A
Employees
51
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$25.80 million

Miscellaneous

Free Float
N/A
Market Cap
$8,295.00
Optionable
Not Optionable
Beta
N/A
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

This page (OTCMKTS:PARNF) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners